Stryker reported its preliminary results for the fourth quarter and full year of 2017.
Here are five highlights:
1. The company reported a 10 percent boost of net sales to $3.5 billion in the fourth quarter of 2017.
2. For the full year, net sales hit $12.4 billion, a 9.9 percent jump over 2016.
3. Domestically, net sales reached $2.5 billion in the fourth quarter and $9.1 billion for the full year of 2017. International sales reached $1 billion in the fourth quarter and $3.4 billion for the full year of 2017.
4. In the fourth quarter of 2017, the following segments grew:
• Neurotechnology and spine— 11.5 percent
• Orthopedics — 8.1 percent
• MedSurg —10.9 percent
5. For the full year of 2017, the segments increased:
• Neurotechnology and spine — 8.2 percent
• Orthopedics — 6.6 percent
• MedSurg — 13.6 percent
6. Neurotechnology and spine net sales increased to $600 million in the fourth quarter and $2.2 billion for the full year of 2017.
7. The orthopedics net sales reached $1.3 billion for the fourth quarter and $4.7 billion for the full year of 2017. Stryker installed 35 Mako robots around the world in the fourth quarter; U.S. knee sales increased 10.5 percent in the quarter.
8. MedSurg net sales rose to $1.6 billion for the fourth quarter and $5.6 billion for the full year of 2017.
9. Stryker anticipates 2017 adjusted net earnings per diluted share to land near the high end of the previously reported range of $6.45 to $6.50.